Stem Cell Therapy

Akt-expressing cells restore 80-90% of lost myocardial volume following MI

Published in Blood Weekly, August 28th, 2003

Genetically engineered stem cells can restore heart performance and repair the damage caused by a heart attack, according to a new study.

Researchers have tried for years to repair damaged hearts with mesenchymal stem cells - a type of stem cell derived from bone marrow. But they achieved only limited success, in part because most of the stem cells die shortly after being transplanted.

Victor Dzau and colleagues writing in the September 2003 issue of Nature Medicine engineered the stem cells to express Akt, a protein that prevents cell death. After growing the stem cells in culture and introducing the Akt gene, the investigators injected the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2003-08-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry